Impact of Cardiovascular Treatments and Systolic Dysfunction on Nutritional Risk in Patients with Ischemic and Valvular Heart Disease

REFERENCES

• Rasmussen HH, Holst M, Kondrup J: Measuring nutritional risk in hospitals. Clin Epidemiol 2:209–216, 2010.
   Google Scholar
• Roger VL: Epidemiology of heart failure. Circ Res 113:646–659, 2013.
   PubMed Web of Science ®Google Scholar
• Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539, 2008.
   PubMed Web of Science ®Google Scholar
• Anker MS, von Haehling S, Springer J, Banach M, Anker SD: Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Arch Med Sci 9:166–171, 2013.
   PubMed Web of Science ®Google Scholar
• Pureza V, Florea VG: Mechanisms for cachexia in heart failure. Curr Heart Fail Rep 10:307–314, 2013.
   PubMedGoogle Scholar
• McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869, 2012.
   PubMed Web of Science ®Google Scholar
• Florea VG, Moon J, Pennell DJ, Doehner W, Coats AJ, Anker SD: Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study. Int J Cardiol 97:15–20, 2004.
   PubMed Web of Science ®Google Scholar
• Melenovsky V, Kotrc M, Borlaug BA, Marek T, Kovar J, Malek I, Kautzner J: Relationships between right ventricular function, body composition and prognosis in advanced heart failure. J Am Coll Cardiol 62:1660–1670, 2013.
   PubMed Web of Science ®Google Scholar
• Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S: Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361:1077–1083, 2003.
   PubMed Web of Science ®Google Scholar
• Skipper A, Ferguson M, Thompson K, Castellanos VH, Porcari J: Nutrition screening tools: an analysis of the evidence. JPEN J Parenter Enteral Nutr 36:292–298, 2012.
   PubMed Web of Science ®Google Scholar
• de Luis DA, Izaola O, Cuellar L, Terroba MC, Cabezas G, Rojo S, Aller R, Sagrado MG: Nutritional assessment: predictive variables at hospital admission related with length of stay. Ann Nutr Metab 50:394–398, 2006.
   PubMed Web of Science ®Google Scholar
• Kondrup J, Rasmussen HH, Hamberg O, Stanga Z: Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 22:321–336, 2003.
   PubMed Web of Science ®Google Scholar
• von Haehling S, Lainscak M, Springer J, Anker SD: Cardiac cachexia: a systematic overview. Pharmacol Ther 121:227–252, 2009.
   PubMed Web of Science ®Google Scholar
• Korfali G, Gundogdu H, Aydintug S, Bahar M, Besler T, Moral AR, Oguz M, Sakarya M, Uyar M, Kilicturgay S: Nutritional risk of hospitalized patients in Turkey. Clin Nutr 28:533–537, 2009.
   PubMed Web of Science ®Google Scholar
• Almeida AI, Correia M, Camilo M, Ravasco P: Nutritional risk screening in surgery: valid, feasible, easy! Clin Nutr 31:206–211, 2012.
   PubMed Web of Science ®Google Scholar
• Maeder MT, Rickli H, Pfisterer ME, Muzzarelli S, Ammann P, Fehr T, Hack D, Weilenmann D, Dieterle T, Kiencke S, Estlinbaum W, Brunner-La Rocca HP: Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. Am Heart J 163:407–414, 2012.
   PubMed Web of Science ®Google Scholar
• Thakar CV: Perioperative acute kidney injury. Adv Chronic Kidney Dis 20:67–75, 2013.
   PubMed Web of Science ®Google Scholar
• von Haehling S, Jankowska EA, Ponikowski P, Anker SD: Anemia in heart failure: an overview of current concepts. Future Cardiol 7:119–129, 2011.
   PubMedGoogle Scholar
• Sarzynski E, Puttarajappa C, Xie Y, Grover M, Laird-Fick H: Association between proton pump inhibitor use and anemia: a retrospective cohort study. Dig Dis Sci 56:2349–2353, 2011.
   PubMed Web of Science ®Google Scholar
• Jakob SM, Stanga Z: Perioperative metabolic changes in patients undergoing cardiac surgery. Nutrition 26:349–353, 2010.
   PubMed Web of Science ®Google Scholar
• Yang YX, Lewis JD, Epstein S, Metz DC: Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947–2953, 2006.
   PubMed Web of Science ®Google Scholar
• McColl KE: Effect of proton pump inhibitors on vitamins and iron. Am J Gastroenterol 104(Suppl 2):S5–S9, 2009.
   PubMed Web of Science ®Google Scholar
• Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB: Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292:1955–1960, 2004.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study investigators. N Engl J Med 342:145–153, 2000.
   PubMed Web of Science ®Google Scholar
• van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E: Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158,998 patients. Eur Heart J 33:2088–2097, 2012.
   PubMed Web of Science ®Google Scholar
• Langin D: Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 53:482–491, 2006.
   PubMed Web of Science ®Google Scholar
• Toma L, Stancu CS, Sanda GM, Sima AV: Anti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL. Biochem Biophys Res Commun 411:202–207, 2011.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, Masoudi FA, Butler J, McBride PE, Casey DE Jr, McMurray JJ, Drazner MH, Mitchell JE, Fonarow GC, Peterson PN, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL: 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147–e239, 2013.
   Google Scholar
• Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U: EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 16:121–137, 2009.
   PubMed Web of Science ®Google Scholar
• van Venrooij LM, de Vos R, Zijlstra E, Borgmeijer-Hoelen MM, van Leeuwen PA, de Mol BA: The impact of low preoperative fat-free body mass on infections and length of stay after cardiac surgery: a prospective cohort study. J Thorac Cardiovasc Surg 142:1263–1269, 2011.
   PubMed Web of Science ®Google Scholar